MIND MEDICINE MINDMED INC (MNMD) Stock News

USA - NASDAQ:MNMD - CA60255C8850 - Common Stock

14.2 USD

+0.81 (+6.05%)

Last: 10/31/2025, 8:01:11 PM

14.3483 USD

+0.15 (+1.04%)

Pre-Market: 11/3/2025, 8:02:08 AM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

MNMD Latest News, Press Relases and Analysis

All

Press Releases

an hour ago - By: Mind Medicine (MindMed) Inc.

Mind Medicine (MindMed) Inc. Announces Closing of Approximately $259 Million Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

4 days ago - By: Mind Medicine (MindMed) Inc.

MindMed to Report Q3 2025 Financial Results on November 6, 2025

4 days ago - By: Mind Medicine (MindMed) Inc.

Mind Medicine (MindMed) Inc. Announces Pricing of $225 Million Public Offering

3 months ago - By: Benzinga - Mentions: BSAC BGC RMNI MTZ ...

Earnings Scheduled For July 31, 2025

5 days ago - By: Mind Medicine (MindMed) Inc.

Mind Medicine (MindMed) Inc. Announces Proposed Public Offering

20 days ago - By: Mind Medicine (MindMed) Inc.

MindMed Announces New Employee Inducement Grant

21 days ago - By: Benzinga

Mind Medicine Analyst Cites Strong Phase 3 Pipeline For Anxiety, Depression

6 months ago - By: The Motley Fool

Why Mind Medicine Stock Vaulted More Than 8% Higher Today

a month ago - By: Mind Medicine Inc.

MindMed Announces New Employee Inducement Grants

2 months ago - By: Mind Medicine (MindMed) Inc.

New MindMed Retrospective Study Presented at Psych Congress 2025 Reveals High Rates of Suicidal Ideation (SI) in Adults with Generalized Anxiety Disorder (GAD)

2 months ago - By: Mind Medicine Inc.

MindMed Announces New Employee Inducement Grants

2 months ago - By: Mind Medicine Inc.

Journal of the American Medical Association (JAMA) Publishes Results from First-Ever Randomized, Placebo-Controlled Clinical Trial Assessing the Dose-Dependent Efficacy of MM120 (Lysergide D-Tartrate, LSD) in Generalized Anxiety Disorder (GAD)

2 months ago - By: Mind Medicine Inc.

MindMed to Participate in September Investor Conferences

3 months ago - By: The Motley Fool

If You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have Today

3 months ago - By: Mind Medicine Inc.

MindMed Announces New Employee Inducement Grants

3 months ago - By: Yahoo Finance

1 Reason to Buy MindMed (MNMD)

3 months ago - By: Mind Medicine Inc.

MindMed Reports Q2 2025 Financial Results and Business Updates

3 months ago - By: Mind Medicine (MindMed) Inc.

MindMed to Report Second Quarter 2025 Financial Results on July 31, 2025

4 months ago - By: Mind Medicine (MindMed) Inc.

MindMed Announces New Employee Inducement Grants

4 months ago - By: FN Media Group LLC - Mentions: NYSE CMPS SAGE ATAI

Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032

5 months ago - By: Mind Medicine Inc.

MindMed Announces New Employee Inducement Grants

5 months ago - By: Zacks Investment Research

Wall Street Analysts Believe Mind Medicine MindMed (MNMD) Could Rally 237.47%: Here's is How to Trade

5 months ago - By: Mind Medicine Inc.

MindMed to Participate in June Investor Conferences

5 months ago - By: Mind Medicine Inc.

MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer

6 months ago - By: Yahoo Finance

Mind Medicine (MindMed) Inc. (MNMD): Analysts See 285% Upside Potential

6 months ago - By: Yahoo Finance

Why Mind Medicine Stock Vaulted More Than 8% Higher Today